Evaluation of the bioequivalence of tablets and capsules containing the novel anticancer agent R115777 (Zarnestra) in patients with advanced solid tumors

2002 ◽  
Vol 27 (1) ◽  
pp. 61-65 ◽  
Author(s):  
M. Crul ◽  
G. J. De Klerk ◽  
M. Swart ◽  
L. Weiner ◽  
P. A. Palmer ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Anticancer Agent ◽  
Advanced Solid Tumors ◽  
The Novel

scholarly journals A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma

2014 ◽  
Vol 20 (14) ◽  
pp. 3683-3691 ◽  
Author(s):  
Donald W. Northfelt ◽  
Ramesh K. Ramanathan ◽  
Peter A. Cohen ◽  
Daniel D. Von Hoff ◽  
Glen J. Weiss ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Finding ◽  
Advanced Solid Tumors ◽  
The Novel ◽  
Toll Like Receptor ◽  
Finding Study ◽  
Dose Finding Study

Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors

2015 ◽  
Vol 33 (3) ◽  
pp. 594-602 ◽  
Author(s):  
Sarah A. Holstein ◽  
James C. Bigelow ◽  
Richard D. Olson ◽  
Robert E. Vestal ◽  
Gerald M. Walsh ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Advanced Solid Tumors ◽  
The Novel

Phase I/IIa trial of the novel microtubule inhibitor BAL101553 in advanced solid tumors: Phase I completed.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 2562-2562 ◽  
Author(s):  
L Rhoda Molife ◽  
Georgios Imseeh ◽  
Marta Capelan ◽  
Fatima El-Khouly ◽  
Nicola Cresti ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
The Novel ◽  
Microtubule Inhibitor

scholarly journals Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors

2020 ◽  
Vol 9 (7) ◽  
pp. 876-888
Author(s):  
Chirag Patel ◽  
Sanjay Goel ◽  
Manish R. Patel ◽  
Lakshmi Rangachari ◽  
Jayson D. Wilbur ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Anticancer Agent ◽  
Phase 1 ◽  
Qtc Interval ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

A phase I trial of the novel oral taxane BMS-275183 in patients with advanced solid tumors

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2029-2029 ◽  
Author(s):  
L. E. Broker ◽  
F. Y. De Vos ◽  
H. Gall ◽  
J. A. Gietema ◽  
M. Voi ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Trial ◽  
Advanced Solid Tumors ◽  
The Novel

Dose escalation stage of a first-in-class phase I study of the novel oral ERK 1/2 kinase inhibitor BVD-523 (ulixertinib) in patients with advanced solid tumors.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 2506-2506 ◽  
Author(s):  
Jeffrey R. Infante ◽  
Filip Janku ◽  
Anthony W. Tolcher ◽  
Manish R. Patel ◽  
Ryan J. Sullivan ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Phase I Study ◽  
Kinase Inhibitor ◽  
Advanced Solid Tumors ◽  
The Novel

A phase I trial of the novel oral taxane BMS-275183 in patients with advanced solid tumors

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2029-2029 ◽  
Author(s):  
L. E. Broker ◽  
F. Y. De Vos ◽  
H. Gall ◽  
J. A. Gietema ◽  
M. Voi ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Trial ◽  
Advanced Solid Tumors ◽  
The Novel
Sign in / Sign up

Export Citation Format

Share Document